Non-invasive prenatal testing (NIPT) describes a DNA-based blood test that measures the probability of trisomy 21 (Down syndrome), trisomy 18 (Edwards syndrome) and trisomy 13 (Patau syndrome) or 22q11.2 deletion (DiGeorge syndrome), if selected, with greater accuracy than traditional first trimester screening.

NIPT requires a single blood draw which poses no threat to the fetus, and can be done as early as 10 weeks’ gestation.

More information can be found at the Sonic Genetics Website or within the Doctor Information brochure below